263 related articles for article (PubMed ID: 23242471)
1. Circulating levels of lipocalin-2 and retinol-binding protein-4 are increased in psoriatic patients and correlated with baseline PASI.
Romaní J; Caixàs A; Ceperuelo-Mallafré V; Carrascosa JM; Ribera M; Rigla M; Vendrell J; Luelmo J
Arch Dermatol Res; 2013 Mar; 305(2):105-12. PubMed ID: 23242471
[TBL] [Abstract][Full Text] [Related]
2. Effect of narrowband ultraviolet B therapy on inflammatory markers and body fat composition in moderate to severe psoriasis.
Romaní J; Caixàs A; Carrascosa JM; Ribera M; Rigla M; Luelmo J
Br J Dermatol; 2012 Jun; 166(6):1237-44. PubMed ID: 22309899
[TBL] [Abstract][Full Text] [Related]
3. Estimation of tissue and serum lipocalin-2 in psoriasis vulgaris and its relation to metabolic syndrome.
El-Hadidi H; Samir N; Shaker OG; Otb S
Arch Dermatol Res; 2014 Apr; 306(3):239-45. PubMed ID: 24052155
[TBL] [Abstract][Full Text] [Related]
4. The lipocalins retinol-binding protein-4, lipocalin-2 and lipocalin-type prostaglandin D2-synthase correlate with markers of inflammatory activity, alcohol intake and blood lipids, but not with insulin sensitivity in metabolically healthy 58-year-old Swedish men.
Wallenius V; Elias E; Bergstrom GM; Zetterberg H; Behre CJ
Exp Clin Endocrinol Diabetes; 2011 Feb; 119(2):75-80. PubMed ID: 21104585
[TBL] [Abstract][Full Text] [Related]
5. Assessment of lipocalin 2, clusterin, soluble tumor necrosis factor receptor-1, interleukin-6, homocysteine, and uric acid levels in patients with psoriasis.
Ataseven A; Kesli R; Kurtipek GS; Ozturk P
Dis Markers; 2014; 2014():541709. PubMed ID: 24803721
[TBL] [Abstract][Full Text] [Related]
6. Changes of serum lipocalin-2 and retinol binding protein-4 levels in patients with psoriasis and Behçet's disease.
Gul FC; Cicek D; Kaman D; Demir B; Nazik H
Eur J Dermatol; 2015 Apr; 25(2):195-7. PubMed ID: 25547333
[No Abstract] [Full Text] [Related]
7. Psoriasis therapy and cardiovascular risk factors: a 12-week follow-up study.
Coimbra S; Oliveira H; Reis F; Belo L; Rocha S; Quintanilha A; Figueiredo A; Teixeira F; Castro E; Rocha-Pereira P; Santos-Silva A
Am J Clin Dermatol; 2010 Dec; 11(6):423-32. PubMed ID: 20429617
[TBL] [Abstract][Full Text] [Related]
8. Serum AFBP levels are elevated in patients with nonalcoholic fatty liver disease.
Suh JB; Kim SM; Cho GJ; Choi KM
Scand J Gastroenterol; 2014 Aug; 49(8):979-85. PubMed ID: 24957697
[TBL] [Abstract][Full Text] [Related]
9. Serum lipocalin-2 levels are increased in patients with psoriasis.
Kamata M; Tada Y; Tatsuta A; Kawashima T; Shibata S; Mitsui H; Asano Y; Sugaya M; Kadono T; Kanda N; Watanabe S; Sato S
Clin Exp Dermatol; 2012 Apr; 37(3):296-9. PubMed ID: 22300286
[TBL] [Abstract][Full Text] [Related]
10. Retinol-binding protein 4 and lipocalin-2 in childhood and adolescent obesity: when children are not just "small adults".
Kanaka-Gantenbein C; Margeli A; Pervanidou P; Sakka S; Mastorakos G; Chrousos GP; Papassotiriou I
Clin Chem; 2008 Jul; 54(7):1176-82. PubMed ID: 18487287
[TBL] [Abstract][Full Text] [Related]
11. Other inflammatory markers and related factors should be kept in mind in metabolic syndrome with psoriasis patients.
Balta I; Balta S; Demirkol S; Celik T
Arch Dermatol Res; 2013 Jul; 305(5):459-60. PubMed ID: 23479005
[No Abstract] [Full Text] [Related]
12. Circulating lipocalin 2 is associated with body fat distribution at baseline but is not an independent predictor of insulin resistance: the prospective Cyprus Metabolism Study.
Liu X; Hamnvik OP; Petrou M; Gong H; Chamberland JP; Christophi CA; Kales SN; Christiani DC; Mantzoros CS
Eur J Endocrinol; 2011 Nov; 165(5):805-12. PubMed ID: 21885675
[TBL] [Abstract][Full Text] [Related]
13. Lipocalin-2: development, analytical characterization, and clinical testing of a new ELISA.
Stejskal D; Karpísek M; Humenanska V; Hanulova Z; Stejskal P; Kusnierova P; Petzel M
Horm Metab Res; 2008 Jun; 40(6):381-5. PubMed ID: 18393169
[TBL] [Abstract][Full Text] [Related]
14. Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire.
Barrea L; Macchia PE; Tarantino G; Di Somma C; Pane E; Balato N; Napolitano M; Colao A; Savastano S
J Transl Med; 2015 Sep; 13():303. PubMed ID: 26376719
[TBL] [Abstract][Full Text] [Related]
15. Short-Term Regulation of Lipocalin-2 but not RBP-4 During Oral Lipid Tolerance Test and Oral Glucose Tolerance Test.
Schmid A; Leszczak S; Ober I; Schäffler A; Karrasch T
Horm Metab Res; 2016 Feb; 48(2):99-105. PubMed ID: 26069091
[TBL] [Abstract][Full Text] [Related]
16. Relationship of leptin with adiposity and inflammation and resistin with disease severity in psoriatic patients undergoing anti-TNF-alpha therapy.
Pina T; Genre F; Lopez-Mejias R; Armesto S; Ubilla B; Mijares V; Dierssen-Sotos T; Gonzalez-Lopez MA; Gonzalez-Vela MC; Blanco R; Hernández JL; Llorca J; Gonzalez-Gay MA
J Eur Acad Dermatol Venereol; 2015 Oct; 29(10):1995-2001. PubMed ID: 25823684
[TBL] [Abstract][Full Text] [Related]
17. Clinical value of circulating lipocalins and insulin-like growth factor axis in pancreatic cancer diagnosis.
El-Mesallamy HO; Hamdy NM; Zaghloul AS; Sallam AM
Pancreas; 2013 Jan; 42(1):149-54. PubMed ID: 22617715
[TBL] [Abstract][Full Text] [Related]
18. Tumour necrosis factor alpha (TNF-alpha)-converting enzyme (TACE) and soluble TNF-alpha receptor type 1 in psoriasis patients treated with narrowband ultraviolet B.
Serwin AB; Sokolowska M; Chodynicka B
Photodermatol Photoimmunol Photomed; 2007 Aug; 23(4):130-4. PubMed ID: 17598866
[TBL] [Abstract][Full Text] [Related]
19. Effect of exercise training on A-FABP, lipocalin-2 and RBP4 levels in obese women.
Choi KM; Kim TN; Yoo HJ; Lee KW; Cho GJ; Hwang TG; Baik SH; Choi DS; Kim SM
Clin Endocrinol (Oxf); 2009 Apr; 70(4):569-74. PubMed ID: 18710473
[TBL] [Abstract][Full Text] [Related]
20. Gender dimorphic increase in RBP-4 and NGAL in children born after IVF: an epigenetic phenomenon?
Sakka SD; Margeli A; Loutradis D; Chrousos GP; Papassotiriou I; Kanaka-Gantenbein C
Eur J Clin Invest; 2013 May; 43(5):439-48. PubMed ID: 23496280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
